This exceptional in-person Spatial Biology event consists of a two-day symposium and a one-day hands-on in silico based laboratory workshop. The symposium features esteemed experts from pathology, spatial biology, multiplex [….]
Immuno US 2023
Published on :Discuss the latest strategies to harness the immune system for the development of innovative therapeutics
RNA Therapeutics & Delivery Europe 2023
Published on :Join RNA leaders, experts and distinguished scientists in Europe, delivering breakthrough research, technologies & connecting global pharma, biotech and academia for high-level discussions on the latest innovations within the formulation [….]
Flow Cytometry: Principles and Methods
Published on :This four day program is ideal for those who are looking for an in-depth, hands-on introduction to Flow Cytometry. The instructors will focus on a broad spectrum of flow cytometric [….]
Multiplex Immunofluorescence in Immune Oncology, Workshop & Symposium
Published on :This four day program is divided into a two-day symposium with lectures presented by world class scientists in the field of immuno-oncology and with representation by all the main multiplex [….]
Flow Cytometry: Principles, Methods and Applications
Published on :This four day program is ideal for those who are looking for an in-depth, hands-on introduction to Flow Cytometry. Developed and taught by active researchers, this workshop will focus on [….]
Miltenyi Biotec promotes Markus Weiss to Executive Vice President
Published on :Markus Weiss, who in this role is responsible for supporting the North American Business Units and Divisions has 18 years of experience in operationalizing strategy, preserving and growing value, scaling culture as well as business transformations. He is experienced in divisional, regional and country level leadership roles in technology, life science, manufacturing, construction and financial services.
Cerecor Rebrands to Avalo Therapeutics
Published on :Cerecor Rebrands to Avalo Therapeutics. Eighteen months after completing its merger with Aevi Genomic Medicine, Cerecor is rebranding to Avalo Therapeutics. The rebranding to Avalo reflects the company’s aims to focus on three core indications, on immunology, immuno-oncology, and rare genetic diseases.
Myeloid Therapeutics and MaxCyte Enter Clinical and Commercial Licensing Agreement to Advance Myeloid’s Cell Therapy Programs
Published on :Patented high-performance cell-engineering platform to biopharmaceutical partners engaged in drug discovery and development, biomanufacturing and cell therapy, including gene editing and immuno-oncology.
5 Questions with Mark Nardone, PMP, Director, Bio-Trac®
Published on :Mark Nardone is Director and Co-Founder of Bio-Trac®, a biotechnology training program that has served the scientific community for over 37 years, providing hands-on training workshops, designed by active researchers for research scientists, that focus on the latest relevant techniques that are necessary for laboratory research.